GeparSixto: Neoadjuvant Chemotherapy ± Carboplatin in Patients With HER2-Positive or Triple-Negative Early Breast Cancer
Slideset - Adding carboplatin to neoadjuvant chemotherapy significantly improved DFS in triple-negative but not HER2+ early breast cancer.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy